source
- Venture capital continues to flow into biopharma in Q3 2026, favoring later-stage and AI-driven companiesVenture capital funding into biopharma topped $16 billion in the first half of 2026 and kept rising in the third quarter, according to industry sources. Investors remain selective, directing money…
- Stryker appoints Spencer Stiles as CEO, Kevin Lobo to become Executive ChairStryker announced a leadership change, naming Spencer Stiles as the new chief executive officer. Stiles, who has been president and COO, will also join the board. Kevin Lobo, who has led the compa…